1-2 of 2
Francisco Perez Leal, MD
Close
Sort by
Journal Articles

Long Term Survival Analysis of Multiple Myeloma Patients Receiving Induction Therapy+ Autologous STEM CELL Trasplantation, Comparing Velcade-Dexametasone to Alkylating Polichemotherapy As Induction Therapy

Sara Caceres, MD, Rocio Cardesa, MD, Carmen Cabrera, M. Helena Bañas, MD, Fatima Ibañez, MD, Julio Prieto, MD, Jorge Groiss, MD, Damian Toran, Carmen Hernandez, Ortegon Sergio, Duvos Elena, MD, Maria Soledad Casado, MD, Esperanza Cerezo, Raul Siguenza, Sara Suarez-Varela, Fernando Carnicero, Maria Luisa Martin Mateos, Maria J. Arcos, Angel Rodriguez, Baldomero Moriano, Ignacio Casas, Francisco Perez Leal, MD, Teresa Vazquez Godoy, Jose M. Bagace, Miguel A. Sanz, MD, Juan Miguel Miguel Bergua Burgues
Journal: Blood
Blood (2018) 132 (Supplement 1): 5764.
https://doi.org/10.1182/blood-2018-99-116924
Published: 2018
Journal Articles

Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia

Ariel Felipe Grajales-Cruz, MD, Julio C. Chavez, MD, Elyce P. Turba, MSN, RN, Lisa Nodzon, PhD ARNP, AOCNP, Francisco Perez Leal, MD, Jose Sandoval-Sus, MD, Rami S. Komrokji, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Bijal D. Shah, MD, Lubomir Sokol, MD PhD, Celeste M. Bello, MD, Javier Pinilla Ibarz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3150.
https://doi.org/10.1182/blood-2018-99-111564
Published: 2018